A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.
Also called NCT01316094
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 165 participants
- Sponsor
- Registry
-
NCT01316094
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01316094. Randomized; quadruple masking; primary purpose treatment. Start 2011-01-18 (actual); primary completion 2012-11-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ASP1941
- Intervention (Drug)
- placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01316094- Content hash
9c7f49b3459d2f5e359366fe323009fc0445b9418783155ba4795dbedaadc0c1